Denise, Jack, Magda, Winnie, Kathy and Kathy

Thank you so much for sending your opinions, thoughts and information.  Yes,
this is an HIV-transmission study, looking at the effect of nevirapine on
mother-to-child transmission.  I believe that the nevirapine will be
discontinued at 24 weeks, which means that the babies will no longer be
protected against of the virus in the breastmilk after that time.  I have
not seen the protocol, but I would speculate that, since this is the case,
the mothers are invited to choose about whether to continue breastfeeding or
not.  I am told that the study is being funded and overseen by a large US
organization and much, much larger numbers of babies from Uganda, Kenya,
South Africa and Zimbabwe will be included in the next phase of the research
if this one goes as expected.  This is the seventh and eighth study
involving replacement feeding (all organized by US-based or Australian
organizations) that I have heard about in this country in the last couple of
years.

If anyone else wants to comment on the above, or to send more thoughts on
what is the "best" replacement feed, I'm listening!

Thanks again.  Comments so far have been very, very helpful.

Pamela Morrison IBCLC, Zimbabwe
[log in to unmask]

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html